John H. Suh mainly focuses on Radiation therapy, Surgery, Radiosurgery, Internal medicine and Oncology. His Radiation therapy study incorporates themes from Survival rate, Retrospective cohort study, Nuclear medicine, Metastasis and Recursive partitioning. The concepts of his Surgery study are interwoven with issues in Biopsy and Adverse effect.
His Radiosurgery research is multidisciplinary, incorporating elements of Cancer, Central nervous system disease, Brain metastasis, Radiography and Survival analysis. As a part of the same scientific family, he mostly works in the field of Internal medicine, focusing on Gastroenterology and, on occasion, Thyroid and Recurrent Glioma. His studies in Oncology integrate themes in fields like Breast cancer, Proportional hazards model, Efaproxiral and Multivariate analysis.
John H. Suh spends much of his time researching Radiosurgery, Internal medicine, Radiation therapy, Oncology and Radiology. The Radiosurgery study which covers Nuclear medicine that intersects with Radiation treatment planning. His work on Cancer, Temozolomide and Proportional hazards model as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Radiation therapy study is related to the wider topic of Surgery. His study in Oncology is interdisciplinary in nature, drawing from both Breast cancer, Whole brain radiation therapy, Glioblastoma and Cohort. His specific area of interest is Radiology, where John H. Suh studies Stereotactic body radiation therapy.
His scientific interests lie mostly in Radiosurgery, Internal medicine, Oncology, Radiology and Radiation therapy. His Radiosurgery research incorporates elements of Meta-analysis, MEDLINE, Retrospective cohort study and Cohort. His research integrates issues of Glioblastoma and Glioma in his study of Internal medicine.
John H. Suh combines subjects such as Brain metastasis, Epidermal growth factor receptor, Low-Grade Glioma, Temozolomide and Melanoma with his study of Oncology. His Radiology research includes elements of Oligodendroglioma, Systematic review, Prospective cohort study and Dose escalation. Within one scientific family, he focuses on topics pertaining to Disease under Radiation therapy, and may sometimes address concerns connected to Neuroimaging.
Radiosurgery, Brain metastasis, Internal medicine, Radiology and Radiation therapy are his primary areas of study. His Radiosurgery research includes themes of MEDLINE, Guideline, Meta-analysis, Vertebral compression fracture and Meningioma. His Brain metastasis research integrates issues from Retrospective cohort study, Lesion, Lung cancer and Cumulative incidence.
His research in Internal medicine intersects with topics in Oncology and Glioma. His Oncology research is multidisciplinary, incorporating perspectives in Breast cancer, Chemotherapy, Epidermal growth factor receptor and Lapatinib. His Radiation therapy research incorporates themes from Neuroimaging, Cancer, Clinical trial and Disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu.
Journal of Clinical Oncology (2012)
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo.
International Journal of Radiation Oncology Biology Physics (2009)
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
William F. Harstell;Charles B. Scott;Deborah Watkins Bruner;Charles W. Scarantino.
Journal of the National Cancer Institute (2005)
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C. Buckner;Edward G. Shaw;Stephanie L. Pugh;Arnab Chakravarti.
The New England Journal of Medicine (2016)
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Paul D. Brown;Stephanie Pugh;Nadia N. Laack;Jeffrey S. Wefel.
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases.
Penny K Sneed;John H Suh;Steven J Goetsch;Seema N Sanghavi.
International Journal of Radiation Oncology Biology Physics (2002)
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani.
Lancet Oncology (2015)
Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases
Minesh P. Mehta;Patrick Rodrigus;C. H J Terhaard;Aroor Rao.
Journal of Clinical Oncology (2003)
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery
Samuel T. Chao;John H. Suh;Shanker Raja;Shih Yuan Lee.
International Journal of Cancer (2001)
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu.
International Journal of Radiation Oncology Biology Physics (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: